TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
+17.76%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$351M
AUM Growth
+$351M
(+44%)
Cap. Flow
+$99.6M
Cap. Flow
% of AUM
28.41%
Top 10 Holdings %
Top 10 Hldgs %
55.99%
Holding
72
New
20
Increased
10
Reduced
9
Closed
31
Top Buys
| 1 |
Biogen
BIIB
|
$24.2M |
| 2 |
Neurocrine Biosciences
NBIX
|
$20.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$20.7M |
| 4 |
GSK
GSK
|
$12.1M |
| 5 |
Eli Lilly
LLY
|
$11.5M |
Top Sells
| 1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$13.5M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$11.5M |
| 3 |
Evolent Health
EVH
|
$9.98M |
| 4 |
BLU
BELLUS Health Inc.
BLU
|
$9.71M |
| 5 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$7.08M |
Sector Composition
| 1 | Healthcare | 97.22% |
| 2 | Consumer Staples | 2.78% |
| 3 | Energy | 0% |
| 4 | Financials | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Xenon Pharmaceuticals
XENE
$2.99B
| $4.85M | 1.33% |
134,331
-32,068
| -19% | -$1.16M |
|
27
Ventyx Biosciences
VTYX
$184M
| $4.36M | 1.2% |
+125,000
| New | +$4.36M |
|
28
X4 Pharmaceuticals
XFOR
$70M
| $4.28M | 1.18% |
2,504,006
+765,706
| +44% | +$1.31M |
|
29
Inspire Medical Systems
INSP
$2.53B
| $4.15M | 1.14% |
23,412
-8,293
| -26% | -$1.47M |
|
|
ISEE
30
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.42M | 0.94% |
+190,597
| New | +$3.42M |
|
31
Beam Therapeutics
BEAM
$1.9B
| $2.56M | 0.7% |
+53,754
| New | +$2.56M |
|
32
CRISPR Therapeutics
CRSP
$4.82B
| $2.38M | 0.65% |
+36,460
| New | +$2.38M |
|
|
BLU
33
DELISTED
BELLUS Health Inc.
BLU
| $2.27M | 0.62% |
214,661
-919,747
| -81% | -$9.71M |
|
34
Altimmune
ALT
$325M
| $2.01M | 0.55% |
157,303
-417,343
| -73% | -$5.33M |
|
35
Vaxcyte
PCVX
$4.17B
| $1.91M | 0.52% |
+79,411
| New | +$1.91M |
|
36
FibroGen
FGEN
$48.4M
| $967K | 0.27% |
+74,348
| New | +$967K |
|
37
Arcellx
ACLX
$3.95B
| $804K | 0.22% |
+42,826
| New | +$804K |
|
38
Leap Therapeutics
LPTX
$12M
| $626K | 0.17% |
+711,798
| New | +$626K |
|
39
Femasys
FEMY
$12M
| $120K | 0.03% |
106,606
+22,775
| +27% | +$25.6K |
|
|
HZNP
40
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-68,750
| Closed | -$5.48M |
|
|
CCXI
41
DELISTED
ChemoCentryx, Inc.
CCXI
| – | – |
-545,532
| Closed | -$13.5M |
|
|
ITCI
42
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-111,572
| Closed | -$6.37M |
|
|
MKFG
43
DELISTED
Markforged Holding Corporation
MKFG
| – | – |
-17,585
| Closed | -$33K |
|
44
Wheels Up
UP
$1.63B
| – | – |
-19,892
| Closed | -$39K |
|
45
Travere Therapeutics
TVTX
$1.75B
| – | – |
-162,014
| Closed | -$3.93M |
|
46
Shattuck Labs
STTK
$61.3M
| – | – |
-13,230
| Closed | -$54K |
|
47
Skillsoft
SKIL
$133M
| – | – |
-10,891
| Closed | -$38K |
|
48
Cassava Sciences
SAVA
$107M
| – | – |
0
| – | – |
|
49
Transocean
RIG
$2.82B
| – | – |
-19,683
| Closed | -$66K |
|
50
Protagonist Therapeutics
PTGX
$3.62B
| – | – |
0
| – | – |
|